COVID-19: CDC Advisory Committee Hones in on Vaccine Rollout Recommendations (includes Beth Bell)

Jake EllisonUW News

When a vaccine to fight COVID-19 has been approved by the FDA for distribution, it’s unlikely that at first there will be enough doses for everyone. Consequently, the United States will need an equitable and effective plan for who gets those first doses, how they get them and who’s next.

Just as important, that plan — like the vaccine itself — has to be trusted and accepted by the general public.

Evidence Related to Schools During the COVID-19 Pandemic

Most countries world-wide implemented localized or national school closures in response to the COVID-19 pandemic, with estimates of >65% of enrolled children globally affected by school closures.1 Since the early pandemic, schools in many settings around the world have fully or partially re-opened for in-person instruction, while in other settings schools have re-opened exclusively using online learning.

Video: Preserving the Scientific Integrity of Getting to COVID-19 Vaccines: From Clinical Trials to Public Allocation

More than 5,200 viewers joined us last week for the Johns Hopkins University–University of Washington symposium “Preserving the Scientific Integrity of Getting to COVID-19 Vaccines: From Clinical Trials to Public Allocation.”

Thank you to those who watched and heard from prominent experts, including scientists from JHU and the UW, who provided insight into the scientific process around developing effective and safe vaccines for COVID-19, and the importance of maintaining scientific integrity and public trust.

Pages